Orient EuroPharma Co., Ltd. (TPEX:4120)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
46.55
+0.25 (0.54%)
Apr 29, 2026, 9:16 AM CST
4.26%
Market Cap 4.02B
Revenue (ttm) 4.60B
Net Income (ttm) -567.39M
Shares Out 86.75M
EPS (ttm) -6.54
PE Ratio n/a
Forward PE n/a
Dividend 4.00 (8.61%)
Ex-Dividend Date n/a
Volume 1,000
Average Volume 23,658
Open 46.55
Previous Close 46.30
Day's Range 46.55 - 46.55
52-Week Range 42.60 - 58.90
Beta 0.14
RSI 45.60
Earnings Date May 12, 2026

About Orient EuroPharma

Orient EuroPharma Co., Ltd., a pharmaceutical company, develops and manufactures drugs worldwide. Its prescription medicines include weight management, andrology, cardiovascular, respiratory, neurology, cardiovascular, metabolism, obstetrics and gynecology, antibiotic, immunology, and anti-cancer drugs. The company also provides nutrition and baby care products, such as milk under the Karihome brand name; and healthcare supplements for liquid nutrition, regular blood lipids, L-arginines, agile movements, and improved sleep qualities under the N... [Read more]

Sector Healthcare
Founded 1982
Employees 339
Stock Exchange Taipei Exchange
Ticker Symbol 4120
Full Company Profile

Financial Performance

In 2025, Orient EuroPharma's revenue was 4.60 billion, an increase of 4.64% compared to the previous year's 4.39 billion. Losses were -567.39 million, 99.8% more than in 2024.

Financial Statements

News

There is no news available yet.